Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-14

Serotonin receptors and transporter: molecular, functional and therapeutic aspects

Objetivo



Serotonin (5-hydroxytryptamine, S-HT) is a major neurotransmitter in the central nervous system.
Currently, 7 types (5-HT1 7) and no less than 15 subtypes of 5-HT receptors have been described. All of them are G-protein linked, with the exception of the 5-HT3 receptor which is a ligand-gated ion channel.
5-HT receptors appear to be involved in basic and integrated physiological processes of the brain (e.g.
presynaptic control of neurotransmitter release, sleep, memory, mood) as well as in socially relevant pathologies (depression, generalised anxiety, obsessive compulsion, dementia, and parkinsonism) and the psychic effects of drugs of abuse (LSD, cocaine, ecstasy).
All the above mentioned diseases share depressive symptomatology, and treatment with antidepressants proves to be of beneficial effect. One of the major targets of antidepressants is the 5-HT transporter, responsible for 5-HT reuptake by serotoninergic neurones. However, treatment with selective 5-HT transporter blockers produces profound modifications in 5-HT receptor responsiveness, which may be also involved in the therapeutic effects of antidepressants.
The understanding of the mechanisms of cellular transduction of 5-HT receptor-mediated signals, as well as of plasticity and degeneration of the 5-HT system, is crucial for developing new drugs and pharmacological strategies for managing these pathologies.
The proposed research aims to elucidatethe roles of 5-HT receptors and 5-HT transporter in physiology and pathology.
The measurable objectives of the present proposal will be:
1) Development of a new preparation of purified serotoninergic synaptosomes suitable for studying, with patch clamp recording, the effects and the mechanisms of action of selective 5-HT agonists (or antagonists) on presynaptic terminals, i.e. at the very site of 5-HT release. This preparation will be adapted also to the dynamic study of intrasynaptosomal calcium. 2) An advancement of knowledge on the cellular mechanisms triggered by stimulation of selected subtypes of 5-HT receptors, namely 5-HTIA, 5-HTlDß, 5-HT7.
3) Functional studies in-vivo will elucidate the relative contributions of 5-HT1A and 5-HTlDß receptors in the modulation of 5-HT release in different brain areas, and investigate the modifications of this balance induced by treatments with antidepressants.
Achievement of these goals will possibly allow identification of receptor subtypes and molecular targets for designing innovative pharmaceutical compounds.
4) Assessment of the changes in expression and responsiveness of several subtypes of 5-HT receptors brought about by pathological states or by administration of drugs of abuse or for management of such pathologies. In particular, the alterations in 5-HT neuro-transmission caused by drugs of abuse, such as "ecstasy", or by treatment with antidepressants will be analysed in animal models including a model of Parkinson disease in primates. 5) Assessment of the changes in density, affinity and distribution of several subtypes of 5-HT receptors associated with Alzheimer disease or induced by treatment with antidepressants in various human brain areas. This new information will possibly allow identification of receptor subtypes as targets for directing new strategies of pharmacological treatment of pathological states.

Ámbito científico (EuroSciVoc)

CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural. Véas: El vocabulario científico europeo..

Para utilizar esta función, debe iniciar sesión o registrarse

Programa(s)

Programas de financiación plurianuales que definen las prioridades de la UE en materia de investigación e innovación.

Tema(s)

Las convocatorias de propuestas se dividen en temas. Un tema define una materia o área específica para la que los solicitantes pueden presentar propuestas. La descripción de un tema comprende su alcance específico y la repercusión prevista del proyecto financiado.

Convocatoria de propuestas

Procedimiento para invitar a los solicitantes a presentar propuestas de proyectos con el objetivo de obtener financiación de la UE.

Datos no disponibles

Régimen de financiación

Régimen de financiación (o «Tipo de acción») dentro de un programa con características comunes. Especifica: el alcance de lo que se financia; el porcentaje de reembolso; los criterios específicos de evaluación para optar a la financiación; y el uso de formas simplificadas de costes como los importes a tanto alzado.

CSC - Cost-sharing contracts

Coordinador

Institut National de la Santé et de la Recherche Médicale
Aportación de la UE
Sin datos
Dirección
91,Boulevard de l'Hôpital
75013 Paris
Francia

Ver en el mapa

Coste total

Los costes totales en que ha incurrido esta organización para participar en el proyecto, incluidos los costes directos e indirectos. Este importe es un subconjunto del presupuesto total del proyecto.

Sin datos

Participantes (5)

Mi folleto 0 0